Interaction of FGF21/SHBG/RBP4 and adiponectin could reduce fatty acid synthesis and enhance FAO via activation of AMPK, and then resist steatosis and increase insulin sensitivity, but also could activate PPARα and inhibit NF-kB pathway. Here, RBP4 is linked to steatosis.